Cargando…

The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies

Detalles Bibliográficos
Autores principales:	Einsele, Hermann, Briones, Javier, Ciceri, Fabio, García Cadenas, Irene, Falkenburg, Fred, Bolaños, Natacha, Heemskerk, H.M. Mirjam, Houot, Roch, Hudecek, Michael, Locatelli, Franco, Morgan, Kate, Morris, Emma C., O’Dwyer, Michael, Sierra, Jordi Gil, van den Brink, Marcel, van de Loosdrecht, Arjan A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432635/ https://www.ncbi.nlm.nih.gov/pubmed/34522844 http://dx.doi.org/10.1097/HS9.0000000000000642

Ejemplares similares

Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
por: Einsele, Hermann, et al.
Publicado: (2020)

The EHA Research Roadmap: Infections in Hematology
por: Cordonnier, Catherine, et al.
Publicado: (2021)

The EHA Research Roadmap: Platelet Disorders
por: Balduini, Carlo, et al.
Publicado: (2021)

The EHA Research Roadmap: Anemias
por: Iolascon, Achille, et al.
Publicado: (2021)

The EHA Research Roadmap: Transfusion Medicine
por: Stanworth, Simon J., et al.
Publicado: (2022)

The EHA Research Roadmap: Normal Hematopoiesis
por: Jaffredo, Thierry, et al.
Publicado: (2021)

The EHA Research Roadmap: Blood Coagulation and Hemostatic Disorders
por: Eichinger, Sabine, et al.
Publicado: (2021)

EHA Research Roadmap on Hemoglobinopathies and Thalassemia: An Update
por: Iolascon, Achille, et al.
Publicado: (2019)

Correction Notice: The EHA Research Roadmap: Anemias
Publicado: (2021)

The EHA Research Roadmap: Malignant Myeloid Diseases
por: Döhner, Hartmut, et al.
Publicado: (2021)

The EHA Research Roadmap: Malignant Lymphoid Diseases
por: Dreyling, Martin, et al.
Publicado: (2022)

The EHA Research Roadmap: Hematopoietic Stem Cells and Allotransplantation
por: Fibbe, Willem, et al.
Publicado: (2022)

EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Myelodysplastic Syndromes
por: van de Loosdrecht, Arjan A., et al.
Publicado: (2022)

The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy
por: Naldini, Luigi, et al.
Publicado: (2022)

The Renovated Face of EHA Classical Master Class: A Survey-based Evaluation on Behalf of the EHA Campus Working Group
por: Gurnari, Carmelo, et al.
Publicado: (2022)

Research Commentary: A Carer’s Roadmap for Research, Practice, and Policy on Suicide, Homicide, and Self-Harm
por: Liabo, Kristin, et al.
Publicado: (2019)

Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
por: Dimopoulos, Meletios A., et al.
Publicado: (2021)

Telemedicine Networks of EHAS Foundation in Latin America
por: Prieto-Egido, Ignacio, et al.
Publicado: (2014)

EHA2021 Virtual Congress Abstract Book
Publicado: (2021)

Fair Pricing of Innovative Medicines: An EHA Position Paper
por: Hagenbeek, Anton, et al.
Publicado: (2020)

Double Hit Lymphoma Diagnosis and Treatment in Europe—A Cross-Sectional Survey of Clinical Practice by the EHA Lymphoma Working Party (EHA LyG)
por: Aurer, Igor, et al.
Publicado: (2020)

Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance
por: Schutgens, Roger E.G., et al.
Publicado: (2023)

Access to Affordable Orphan Medicines in Europe: An EHA Position Paper
por: Merlini, Giampaolo, et al.
Publicado: (2020)

Personalized Treatment for Hematologic Diseases in Europe: An EHA Position Paper
por: Jäger, Ulrich, et al.
Publicado: (2020)

EHA Endorsement of the European Guidelines for Myelodysplastic Syndromes, MDS-RIGHT
por: Blum, Sabine, et al.
Publicado: (2021)

EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer
por: Falanga, Anna, et al.
Publicado: (2022)

Reprogramming of Virus-specific T Cells into Leukemia-reactive T Cells Using T Cell Receptor Gene Transfer
por: Heemskerk, Mirjam H.M., et al.
Publicado: (2004)

EHA Endorsement of ESMO Clinical Practice Guidelines for Marginal Zone Lymphomas
por: Ladetto, Marco, et al.
Publicado: (2020)

EHA Scientific Working Groups: Connecting Science and Spreading Knowledge in Hematology
por: Sonneveld, Pieter
Publicado: (2020)

The EHA2021 Annual Congress Award Winners: Celebrating Excellence in Hematology
por: Gribben, John, et al.
Publicado: (2021)

The Design and Testing of a PEA Powered Ankle Prosthesis Driven by EHA
por: Huang, Qitao, et al.
Publicado: (2022)

EHA Endorsement of the Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia
por: Rössler, Jochen, et al.
Publicado: (2021)

Reporting From the First EHA Research Conference: Exciting Science With Panoramic Views
por: Tesio, Melania
Publicado: (2023)

Extracellular Domains of CD8α and CD8ß Subunits Are Sufficient for HLA Class I Restricted Helper Functions of TCR-Engineered CD4(+) T Cells
por: van Loenen, Marleen M., et al.
Publicado: (2013)

P808: CONTROLLED FRATRICIDE TO AUGMENT ANTI-MYELOMA REACTIVITY OF SLAMF7 AND CD38 CAR T CELLS
por: Konetzki, Verena, et al.
Publicado: (2023)

EU-Wide Access to High-quality, Affordable Precision Diagnostics: An EHA Position Paper
por: Macintyre, Elizabeth, et al.
Publicado: (2020)

EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma
por: Ladetto, Marco, et al.
Publicado: (2021)

Flavor of Iron at EHA2023: Novel Regulatory Mechanisms and Therapeutic Options for the Correction of Anemia
por: Vinchi, Francesca, et al.
Publicado: (2023)

Summary of Joint European Hematology Association (EHA) and EuroBloodNet Recommendations on Diagnosis and Treatment of Methemoglobinemia
por: Iolascon, Achille, et al.
Publicado: (2021)

Human iPSC-derived preclinical models to identify toxicity of tumor-specific T cells with clinical potential
por: van Amerongen, Rosa A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_92i273qhd28o1rigqkbtnt4f7h